Literature DB >> 27268966

Applicability of two automated disintegration apparatuses for rapidly disintegrating (mini)tablets.

Daniel Sieber1, Alessia Lazzari1,2, Julian Quodbach1, Miriam Pein1.   

Abstract

OBJECTIVES: Orally disintegrating (mini)tablets (OD(M)Ts) are of interest in the field of pharmaceutics. Their orodispersible character is defined by the disintegration time, which is measured with a basket apparatus according to the European Pharmacopoeia. This method, however, lacks applicability for ODTs and especially ODMTs. New disintegration apparatuses have been described in literature, but a qualification to assess the applicability has not been described. A qualification procedure for two automated disintegration apparatuses, OD-mate and Hermes apparatus, is introduced.
METHODS: Aspects of the operational qualification as well as precision and accuracy regarding a performance qualification were evaluated for both apparatuses analog to the ICH guideline Q2. While the OQ study is performed separately for each apparatus, accuracy and precision were performed following the same protocol for both testers. KEY
FINDINGS: Small RSDs (16.9% OD-mate; 15.2% Hermes compared to 32.3% for the pharmacopeial method) were found despite very fast disintegration times (1.5 s for both apparatuses). By comparing these RSDs to practical examples, the authors propose threshold values for repeatability depending on the mean disintegration time. Obtained results from the qualification were used to assess the applicability of both apparatuses.

Entities:  

Keywords:  Disintegration; OD-mate; ODMT; minitablets; qualification procedure

Mesh:

Substances:

Year:  2016        PMID: 27268966     DOI: 10.1080/10837450.2016.1189935

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  1 in total

1.  Implementing the Design of Experiments (DoE) Concept into the Development Phase of Orodispersible Minitablets (ODMTs) Containing Melatonin.

Authors:  Arkadiusz Hejduk; Michał Teżyk; Emilia Jakubowska; Klaudia Krüger; Janina Lulek
Journal:  AAPS PharmSciTech       Date:  2022-01-20       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.